FCGR3A and colorectal carcinoma: To determine the role of CD16A genotypes in the genetic susceptibility to CRC and pathological stage, we compared the 559G/T (158, V/F) and 230A/G/T (48, H/R/L) allele polymorphisms in CRC patients and LCTRs (Table 4).